Study of genetic elements in sepsis and aging
Part of Infections clinical trials.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the intensive care unit (ICU) with sepsis, a severe response to infection.
- You have a SOFA score of 2 or higher, which measures organ function.
- You do not have a bleeding disorder like DIC or hemorrhagic shock.
- You do not have a long-term low red blood cell count (hemoglobin below 7.0).
- You are not taking immune-suppressing drugs after an organ transplant, and you have not had CAR-T cell therapy for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores how changes in RNA (a molecule that helps your cells function) might cause long-term immune issues after sepsis, a severe infection. It compares septic patients, critically ill patients without infection, and healthy volunteers to understand these effects.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.